Research and development - Press Releases

Date	Title	Company
18-Apr-2023	Nouscom Presents New Positive Translational Phase 1b Data of NOUS-PEV, a Personalized Neoantigen Cancer Immunotherapy, in a Late-Breaking Abstract at AACR 2023	Nouscom
18-Apr-2023	Trading Update	Kromek Group plc
18-Apr-2023	Seven-Year Agreement with Tier 1 OEM	Kromek Group plc
18-Apr-2023	$4.0 Million Grant Award from the Medical Technology Enterprise Consortium	Spectral MD Holdings, Ltd
18-Apr-2023	HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer	HUTCHMED
18-Apr-2023	BioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases	BioSenic
18-Apr-2023	Macomics Presents its ENIGMAC™ Discovery Platform for Gene to Function Target Validation of Novel Macrophage Therapies at AACR	Macomics Ltd
18-Apr-2023	Beckman Coulter Life Sciences Achieves Industry-First Reagent Certification to Help Prepare Labs for IVDR and to Clear Confusion	Beckman Coulter Life Sciences
18-Apr-2023	Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees and Opens Spring 2023 Submissions	Thermo Fisher Scientific
18-Apr-2023	SMART introduces three research initiatives to revolutionise diagnostic capabilities for health applications	Blue Totem Communications
17-Apr-2023	Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile	Vaccitech
17-Apr-2023	Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID	Vedanta Biosciences
17-Apr-2023	Targeting ‘viral footprints’ in our DNA could boost cancer treatment	Francis Crick Institute
17-Apr-2023	Aston University develops software to untangle genetic factors linked to shared characteristics	Aston University
17-Apr-2023	“Some countries’ health systems are simply not equipped to cope with the burden of a natural disaster, a conflict, or a crisis brought on by the insurgence of a virus, such as the Covid-19 pandemic.”	Unimed Procurement Services
11-Apr-2023	Meridian Medical Technologies, a Kindeva Drug Delivery Company, Investing $100+ Million in Bridgeton, Missouri, Expansion	Meridian Medical Technologies, a Kindeva Drug Delivery Company
11-Apr-2023	Intended Retirement of Independent Non-executive Director	HUTCHMED
11-Apr-2023	Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I	Spectral MD Holdings, Ltd
11-Apr-2023	Canvax strengthens its portfolio with Buffers & Liquids solutions manufactured under GMP grade	Canvax
11-Apr-2023	Discovery Park Ventures grows portfolio with addition of two new investments	Discovery Park Ventures